Technical Support

InertSearch (Application Library)

Index

Application

Document No. Index

LB101 - 200 of Application List

No. Description Column
LB101 Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam tablets) Inertsil WP300 C18
LB102 Analysis of Donepezil hydrochloride (Under the Condition of Japanese Pharmacopoeia, Donepezil hydrochloride tablets) Inertsil ODS-2
LB103 Analysis of Pilsicainide hydrochloride hydrate (Under the Condition of the Japanese Pharmacopoeia) Inertsil ODS-4
LB104 Analysis of Pitavastatin calcium (Under the Condition of the Japanese Pharmacopoeia, Pitavastatin calcium hydrate) Inertsil ODS-4
LB105 Analysis of Pitavastatin calcium Inertsil ODS-4
LB106 Analysis of Pitavastatin calcium tablets (Under the Condition of the draft for the Japanese Pharmacopoeia) Inertsil ODS-4
LB107 Analysis of Pre-column Derivatized Aflatoxin InertSustain C18
LB108 Analysis of Urea Inertsil Amide
LB109 Analysis of Organic acids (InertSustain C18) InertSustain C18
LB110 Analysis of Organic acids (Inertsil ODS-4) Inertsil ODS-4
LB111 Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB112 Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB113 Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB114 Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB115 Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) Inertsil ODS-4
LB116 Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) Inertsil ODS-4
LB117 Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) Inertsil ODS-4
LB118 Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) Inertsil ODS-3
LB119 Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) Inertsil ODS-3
LB120 Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) Inertsil WP300 C18
LB121 Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) Inertsil WP300 C18
LB122 Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) Inertsil WP300 C18
LB123 Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) InertSustain C8
LB124 Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) InertSustain C8
LB125 Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) Inertsil WP300 C18
LB126 Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) Inertsil WP300 C18
LB127 Analysis of Etizolam (Under the Condition of the Japanese Pharmacopoeia, Etizolam Tablets) Inertsil ODS-3
LB128 Analysis of Teprenone (Under the Condition of the Japanese Pharmacopoeia, Teprenone Capsules) Inertsil ODS-2
LB129 Analysis of Amantadine (Inertsil HILIC) Inertsil HILIC
LB130 Analysis of Amantadine (InertSustain C18) InertSustain C18
LB133 Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) Inertsil Ph
LB134 Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) Inertsil Ph
LB135 Analysis of Methylhippuric acid InertSustain Phenyl
LB136 Analysis of Cresol InertSustain Phenyl
LB137 Analysis of Estrogen InertSustain Phenyl
LB138 Analysis of Steroidal anti-inflammatory drug InertSustain Phenyl
LB139 Analysis of Nonsteroidal anti-inflammatory drug InertSustain Phenyl
LB140 Analysis of Sugar InertSustain NH2
LB141 Analysis of Cyclodextrin InertSustain NH2
LB142 Analysis of Sugar alcohol InertSustain NH2
LB143 Analysis of Nucleobase InertSustain NH2
LB144 Analysis of Glucosamine InertSustain NH2
LB145 Analysis of Acarbose InertSustain NH2
LB146 Analysis of Acesulfame potassium InertSustain NH2
LB147 Analysis of Allantoin InertSustain NH2
LB148 Analysis of Cyanocobalamin (Under the Condition of the Japanese Pharmacopoeia) InertSustain C8
LB149 Analysis of Liner alkylbenzene sulfonate (InertSustain C18 HP) InertSustain C18 HP
LB150 Analysis of Liner alkylbenzene sulfonate (Inertsil C8-4 HP) Inertsil C8-4 HP
LB151 Analysis of Liner alkylbenzene sulfonate (InertSustain C18 HP) InertSustain C18 HP
LB152 Analysis of Epinastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Epinastine Hydrochloride Tablets) Inertsil C8-4
LB153 Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) Inertsil ODS-SP
LB154 Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) Inertsil ODS-4
LB155 Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) Inertsil ODS-4
LB156 Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) Inertsil ODS-4
LB157 Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB158 Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) Inertsil WP300 C18
LB159 Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB160 Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) Inertsil WP300 C18
LB161 Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) InertSustain C18
LB162 Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) Inertsil WP300 C18
LB163 Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia) Inertsil ODS-SP
LB164 Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia, Telmisartan Tablets) Inertsil ODS-4
LB165 Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia, Pravastatin Sodium Tablets) Inertsil ODS-4
LB166 Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) Inertsil WP300 C18
LB167 Analysis of Crospovidone (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB171 Analysis of Protein Monocap C18 Fast-flow
LB172 Analysis of Tryptophan metabolites Monocap C18 Fast-flow
LB173 Analysis of Azelastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB174 Analysis of d-Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia) Inertsil ODS-3
LB175 Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) InertSustain C18
LB176 Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) InertSustain C18
LB177 Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) InertSustain C18
LB178 Analysis of Hydrochlorothiazide Inertsil WP300 C18
LB179 Analysis of Erythromycin Inertsil ODS-4 HP
LB180 Analysis of Sugars InertSustain NH2
LB181 Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB182 Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB183 Analysis of Phellodendron Bark (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) InertSustain C18
LB184 Analysis of Phellodendron Bark (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) Inertsil ODS-3
LB185 Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) InertSustain C18
LB186 Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) InertSustain C18
LB187 Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) InertSustain C18
LB188 Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) Inertsil C8-3
LB189 Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) InertSustain C8
LB190 Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) Inertsil C8-3
LB191 Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) InertSustain C8
LB192 Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) Inertsil C8-3
LB193 Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) InertSustain C8
LB194 Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) Inertsil C8-3
LB195 Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) InertSustain C8
LB196 Analysis of Ciprofloxacin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ciprofloxacin hydrochloride hydrate) InertSustain C18
LB197 Analysis of Leucine and Isoleucine Inertsil Amide
LB198 Analysis of Steroidal anti-inflammatory drug InertSustain Phenyl
LB199 Analysis of Vitamin E Inertsil NH2
LB200 Analysis of Losartan potassium and Hydrochlorothiazide (Under the Condition of USP 35-NF30, Losartan potassium and Hydrochlorothiazide Tablets) Inertsil C8-3